8-K 1 r8kaug7.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: August 7, 2003 (Date of earliest event reported) BIO-RAD LABORATORIES, INC. ________________________________________________________________ (exact name of registrant as specified in its charter) Commission File: 1-7928 Delaware 94-1381833 ________________________________________________________________ (State or other (I.R.S. Employer jurisdiction of Identification No.) incorporation or organization) 1000 Alfred Nobel Drive Hercules, California 94547 ________________________________________________________________ (Address of Principal executive offices, including zip code) (510) 724-7000 ________________________________________________________________ (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS On August 7, 2003, Bio-Rad Laboratories, Inc. issued a press release announcing that it has agreed to sell $225,000,000 aggregate principal amount of its 7.50% Senior Subordinated Notes due 2013 in a private offering. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ITEM 7. FINANCIAL STATEMENT, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS (c) Exhibits Exhibit Number Description 99.1 Press Release for pricing of private offer of Bio-Rad Laboratories, Inc., dated August 7, 2003. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-RAD LABORATORIES, INC. Date: August 7, 2003 By:/s/ James R. Stark James R. Stark Corporate Controller EXHIBIT INDEX Exhibit Number Description 99.1 Press Release for pricing of private offering of Bio-Rad Laboratories, Inc., dated August 7, 2003.